In this study, we report that FAK activity within CAFs is an independent prognostic marker for PDAC patients (patients with high FAK activity, i.e. high score for pY397 FAK within CAFs, have significantly shorter DFS and OS than patients with low FAK activity), whereas FAK activity within tumour cells is not. This evidence concerns the gene PTK2 and neoplasm.